2004
DOI: 10.3748/wjg.v10.i2.260
|View full text |Cite
|
Sign up to set email alerts
|

Long term persistence of T cell memory to HBsAg after hepatitis B vaccination

Abstract: AIM:To determine if the T cell memory to HBsAg can persist for a long time after hepatitis B (HB) vaccination. METHODS:Thirty one vaccine recipients who were healthcare workers (18 females and 13 males aged 34-58 years) from Utrecht University Hospital, Netherlands, and had previously received a standard course of vaccination for hepatitis B were investigated and another 9 unvaccinated healthy volunteers from the same hospital were used as the control. Blood samples were taken just before the experiment to tes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
31
1

Year Published

2009
2009
2019
2019

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(34 citation statements)
references
References 30 publications
(43 reference statements)
2
31
1
Order By: Relevance
“…15 Moreover, studies in patients vaccinated against hepatitis B virus have demonstrated persistence of HBsAg-specific memory T cells in the circulation for a long time after vaccination, even when serum anti-HBs antibodies were no longer detectable. 33 This phenomenon may also apply to rituximab-treated patients in whom no antibody responses were detected, yet cellular responses were present. It is possible that the effector cytotoxic T cells seen in this group can provide protection against H1N1 infection, supporting vaccination for this subgroup of patients.…”
Section: Discussionmentioning
confidence: 98%
“…15 Moreover, studies in patients vaccinated against hepatitis B virus have demonstrated persistence of HBsAg-specific memory T cells in the circulation for a long time after vaccination, even when serum anti-HBs antibodies were no longer detectable. 33 This phenomenon may also apply to rituximab-treated patients in whom no antibody responses were detected, yet cellular responses were present. It is possible that the effector cytotoxic T cells seen in this group can provide protection against H1N1 infection, supporting vaccination for this subgroup of patients.…”
Section: Discussionmentioning
confidence: 98%
“…17,18 The persistence of immunological memory over 5 years after primary vaccination is apparent from rapid increases in antibody level following booster vaccination, even in subjects who have lost antibodies. [26][27][28][29] This phenomenon clearly represents the presence of the immunological memory exist within the memory B lymphocytes that are induced during the first exposure to antigen, and upon a subsequent exposure to the same antigen, induces rapid production of specific antibody. Moreover, complementary studies using an in vitro cell enzyme linked immunosorbent assay (spot-ELISA) have demonstrated that the number of memory B lymphocytes able to produce anti-HBs antibody is not reduced as the level of antibody declines.…”
Section: 21mentioning
confidence: 99%
“…8,11,13,16,17 It is worth noting that the absence of antibodies (anti-HBs < 10 mIU/ml) in previously immunized subjects does not prove absence of protection. 18,19 There have been studies demonstrating that postvaccinal immunity against hepatitis B is not only humoral, but it has been detected that immunologic memory determined by HBsAg -specifi c T-lymphocytes persists long time after vaccination in recipients with serum antibodies < 10 mIU/ml. 18 The presence of immunologic memory may be proven indirectly by measurement of the immune response to a booster vaccine dose, accepted as anamnestic immune response (AIR).…”
Section: Duration Of the Immune Responsementioning
confidence: 99%